Vladimír Divoký (Vladimir Divoky)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Reactive Oxygen Species

Chronic Myeloid Leukemia

Dna Damage Response

Top Venues

International journal of molecular sciences

International journal of cancer

American journal of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Monika Kaisrlikova, David Kundrat, Pavla Koralkova, Iva Trsova, Zuzana Lenertova, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Jitka Vesela, Martin Vostry, Radka Simeckova, Marketa Stastna Markova, Marie Lauermannova, Anna Jonášová, Jaroslav Cermak, Vladimír Divoký, Monika Belickova
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms. International journal of cancer 154 (9) (2024)
Monika Kaisrlikova, David Kundrat, Pavla Koralkova, Iva Trsova, Zuzana Lenertova, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Jitka Vesela, Martin Vostry, Radka Simeckova, Marketa Stastna Markova, Marie Lauermannova, Anna Jonášová, Jaroslav Cermak, Vladimír Divoký, Monika Belickova
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms. International journal of cancer 154 (9) (2024)
Monika Kaisrlikova, David Kundrat, Pavla Koralkova, Iva Trsova, Zuzana Lenertova, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Jitka Vesela, Martin Vostry, Radka Simeckova, Marketa Stastna Markova, Marie Lauermannova, Anna Jonášová, Jaroslav Cermak, Vladimír Divoký, Monika Belickova
Attenuated cell cycle and DNA damage response transcriptome signatures and overrepresented cell adhesion processes imply accelerated progression in patients with lower-risk myelodysplastic neoplasms. International journal of cancer (2024)
Lucia Vráblová, Vladimír Divoký, Pavla Kořalková, Kateřina Machová Poláková, Eva Kriegová, Romana Janská, Jan Grohmann, Milena Holzerová, Tomáš Papajík, Edgar Faber
Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia. International journal of molecular sciences 24 (3) (2023)
Lucia Vráblová, Vladimír Divoký, Pavla Kořalková, Kateřina Machová Poláková, Eva Kriegová, Romana Janská, Jan Grohmann, Milena Holzerová, Tomáš Papajík, Edgar Faber
Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia. International journal of molecular sciences 24 (3) (2023)
Lucia Vráblová, Vladimír Divoký, Pavla Kořalková, Kateřina Machová Poláková, Eva Kriegová, Romana Janská, Jan Grohmann, Milena Holzerová, Tomáš Papajík, Edgar Faber
Deep Molecular Response Achieved with Chemotherapy, Dasatinib and Interferon α in Patients with Lymphoid Blast Crisis of Chronic Myeloid Leukaemia. International journal of molecular sciences 24 (3) (2023)
Lucie Sochorcova, Katarina Hlusickova Kapralova, Jana Fialova Kucerova, Dagmar Pospisilova, Daniela Prochazkova, Ondrej Jahoda, Simona Kurekova, Barbora Kralova, Martina Divoka, Jana Navratilova, Jirina Manakova, Eva Kriegova, Karel Indrak, Edgar Faber, Vladimír Divoký, Monika Horvathova
Elevated erythroferrone distinguishes erythrocytosis with inherited defects in oxygen-sensing pathway from primary familial and congenital polycythaemia. British journal of haematology (2023)
Jihyun Song, Krishna M Sundar, Monika Horvathova, Radhika Gangaraju, Karel Indrak, Robert D Christensen, Samuel Genzor, Carsten Lundby, Vladimír Divoký, Tomas Ganz, Josef T Prchal
Increased blood reactive oxygen species and hepcidin in obstructive sleep apnea precludes expected erythrocytosis. American journal of hematology (2023)
Monika Kaisrlikova, Jitka Vesela, David Kundrat, Hana Votavova, Michaela Dostalova Merkerova, Zdenek Krejcik, Vladimír Divoký, Marek Jedlicka, Jan Fric, Jiri Klema, Dana Mikulenkova, Marketa Stastna Markova, Marie Lauermannova, Jolana Mertova, Jacqueline Soukupova Maaloufova, Anna Jonášová, Jaroslav Cermak, Monika Belickova
RUNX1 mutations contribute to the progression of MDS due to disruption of antitumor cellular defense: a study on patients with lower-risk MDS. Leukemia 36 (7) (2022)
Barbora Kralova, Lucie Sochorcova, Jihyun Song, Ondrej Jahoda, Katarina Hlusickova Kapralova, Josef T Prchal, Vladimír Divoký, Monika Horvathova
Developmental changes in iron metabolism and erythropoiesis in mice with human gain-of-function erythropoietin receptor. American journal of hematology 97 (10) (2022)
Pavla Koralkova, Monika Belickova, David Kundrat, Michaela Dostalova Merkerova, Zdenek Krejcik, Katarina Szikszai, Monika Kaisrlikova, Jitka Vesela, Pavla Vyhlidalova, Jan Stetka, Alzbeta Hlavackova, Jiří Suttnar, Patrik Flodr, Jan Stritesky, Anna Jonasova, Jaroslav Cermak, Vladimír Divoký
Low Plasma Citrate Levels and Specific Transcriptional Signatures Associated with Quiescence of CD34+ Progenitors Predict Azacitidine Therapy Failure in MDS/AML Patients. Cancers 13 (9) (2021)
Mehrdad Ghashghaeinia, Pavla Koralkova, Daniela Giustarini, Renata Mojzikova, Birgit Fehrenbacher, Peter Dreischer, Martin Schaller, Ulrich Mrowietz, Antonio Martínez-Ruiz, Thomas Wieder, Vladimír Divoký, Ranieri Rossi, Florian Lang, Martin Köberle
The specific PKC-α inhibitor chelerythrine blunts costunolide-induced eryptosis. Apoptosis : an international journal on programmed cell death 25 (9-10) (2021)
Jan Stetka, Jan Gursky, Julie Liñan Velasquez, Renata Mojzikova, Pavla Vyhlidalova, Lucia Vrablova, Jiri Bartek, Vladimír Divoký
Role of DNA Damage Response in Suppressing Malignant Progression of Chronic Myeloid Leukemia and Polycythemia Vera: Impact of Different Oncogenes. Cancers 12 (4) (2020)
Katarina Kapralova, Ondrej Jahoda, Pavla Koralkova, Jan Gursky, Lucie Lanikova, Dagmar Pospisilova, Vladimír Divoký, Monika Horvathova
Oxidative DNA Damage, Inflammatory Signature, and Altered Erythrocytes Properties in Diamond-Blackfan Anemia. International journal of molecular sciences 21 (24) (2020)
Cristina Mambet, Olga Babosova, Jean-Philippe Defour, Emilie Leroy, Laura Necula, Oana Stanca, Aurelia Tatic, Nicoleta Berbec, Daniel Coriu, Monika Belickova, Barbora Kralova, Lucie Lanikova, Jitka Vesela, Christian Pecquet, Pascale Saussoy, Violaine Havelange, Carmen Cristina Diaconu, Vladimír Divoký, Stefan N Constantinescu
Cooccurring JAK2 V617F and R1063H mutations increase JAK2 signaling and neutrophilia in myeloproliferative neoplasms. Blood 132 (25) (2018)